Company profile for Naobios

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Naobios is a bioprocess development and contract manufacturing organization specializing in viral vaccines and viral vectors. Acquired by Clean Biologics in 2019, the company provides end-to-end support for process development and the production of preclinical and clinical batches. With strong expertise in virology, cell culture, and bioprocess optimization, Naobios delivers high-quality, reliable solutions that accelerate vac...
Naobios is a bioprocess development and contract manufacturing organization specializing in viral vaccines and viral vectors. Acquired by Clean Biologics in 2019, the company provides end-to-end support for process development and the production of preclinical and clinical batches. With strong expertise in virology, cell culture, and bioprocess optimization, Naobios delivers high-quality, reliable solutions that accelerate vaccine and gene therapy development while ensuring compliance with global regulatory standards.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
France
Address
Address
6 rue Alain Bombard 44800 Saint-Herblain
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2026-04-13/clean-cells-and-naobios-showcase-complete-end-to-end-viral-vaccines-and-vector-solutions-at-bio-kore

PHARMIWEB
13 Apr 2026

https://www.businesswire.com/news/home/20260309874853/en/Naobios-and-SGS-Partner-to-Manufacture-Respiratory-Syncytial-Virus-RSV-Challenge-Agent

BUSSINESSWIRE
09 Mar 2026

https://www.businesswire.com/news/home/20251023562984/en/Naobios-and-Tokyo-Metropolitan-Institute-of-Medical-Science-Partner-to-Develop-New-Live-attenuated-Vaccine-Against-mpox

BUSINESSWIRE
23 Oct 2025

https://www.businesswire.com/news/home/20250909821000/en/Naobios-Nuvonis-and-European-Vaccine-Initiative-Collaborate-on-Manufacturing-Influenza-Challenge-Agent

BUSINESSWIRE
02 Sep 2025

https://www.businesswire.com/news/home/20241029640727/en

BUSINESSWIRE
29 Oct 2024

https://www.pharmiweb.com/press-release/2021-09-21/naobios-manufactures-flugen-inc-s-m2sr-influenza-vaccine-candidate-for-upcoming-clinical-trials

PHARMBIWEB
21 Sep 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty